{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:15:05Z","timestamp":1788952505149,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007219","name":"Shanghai Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["23ZR1463300"],"award-info":[{"award-number":["23ZR1463300"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2025J02032"],"award-info":[{"award-number":["2025J02032"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bbrc.2026.154461","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T06:46:52Z","timestamp":1787122012000},"page":"154461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Loureirin A, derived from Dragon's blood, promoted drug delivery and efficacy in pancreatic cancer via vascular promotion"],"prefix":"10.1016","volume":"834","author":[{"given":"Jing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinchen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiusong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songyan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shudong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2711-2240","authenticated-orcid":false,"given":"Yan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.154461_bib1","doi-asserted-by":"crossref","DOI":"10.1186\/s12893-023-02091-7","article-title":"Pancreatic cancer surgery","volume":"23","author":"Di Martino","year":"2023","journal-title":"BMC Surg."},{"key":"10.1016\/j.bbrc.2026.154461_bib2","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"NEW ENGL J MED"},{"key":"10.1016\/j.bbrc.2026.154461_bib3","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"NEW ENGL J MED"},{"key":"10.1016\/j.bbrc.2026.154461_bib4","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41571-019-0281-6","article-title":"From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer","volume":"17","author":"Nevala-Plagemann","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2026.154461_bib5","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1136\/gut.2010.226092","article-title":"Stromal biology and therapy in pancreatic cancer","volume":"60","author":"Neesse","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.bbrc.2026.154461_bib6","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1158\/0008-5472.CAN-12-4521","article-title":"Coevolution of solid stress and interstitial fluid pressure in tumors during progression: implications for vascular collapse","volume":"73","author":"Stylianopoulos","year":"2013","journal-title":"Cancer Res."},{"issue":"5933","key":"10.1016\/j.bbrc.2026.154461_bib7","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1126\/science.1171362","article-title":"Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer","volume":"324","author":"Olive","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2026.154461_bib8","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1136\/gutjnl-2012-302529","article-title":"Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer","volume":"62","author":"Jacobetz","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.bbrc.2026.154461_bib9","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","article-title":"Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival","volume":"25","author":"Ozdemir","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2026.154461_bib10","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ccr.2014.04.021","article-title":"Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma","volume":"25","author":"Rhim","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2026.154461_bib11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ccell.2014.10.015","article-title":"Dual-action combination therapy enhances angiogenesis while reducing tumor growth and spread","volume":"27","author":"Wong","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2026.154461_bib12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.addr.2017.07.007","article-title":"Pharmacological and physical vessel modulation strategies to improve EPR-mediated drug targeting to tumors","volume":"119","author":"Ojha","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bbrc.2026.154461_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201902746","article-title":"MT1\u2010MMP\u2010Activated liposomes to improve tumor blood perfusion and drug delivery for enhanced pancreatic cancer therapy","author":"Wei","year":"2020","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bbrc.2026.154461_bib34","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s40265-024-02133-1","article-title":"Liposomal irinotecan: a review as first-line therapy in metastatic pancreatic adenocarcinoma","volume":"85","author":"Brown","year":"2025","journal-title":"Drugs"},{"key":"10.1016\/j.bbrc.2026.154461_bib14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.sjbs.2012.11.005","article-title":"In vitro micropropagation of Dracaena sanderiana Sander ex mast: an important indoor ornamental plant","volume":"20","author":"Aslam","year":"2013","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.bbrc.2026.154461_bib15","doi-asserted-by":"crossref","first-page":"10650","DOI":"10.3390\/molecules190710650","article-title":"A systematic review of the botanical, phytochemical and pharmacological profile of Dracaena cochinchinensis, a plant source of the ethnomedicine \u201cDragon's Blood\u201d","volume":"19","author":"Fan","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2026.154461_bib16","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jep.2007.10.018","article-title":"Dragon's blood: Botany, chemistry and therapeutic uses","volume":"115","author":"Gupta","year":"2008","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bbrc.2026.154461_bib17","first-page":"174","article-title":"Exploring the clinical application of the \"Fuyang Huayin\" Method in Liver Cancer from the Perspective of \"Yang Transforms Qi, Yin Shapes Form\"","volume":"17","author":"Song","year":"2021","journal-title":"ASIA-PACIFIC TRADITIONAL MEDICINE"},{"key":"10.1016\/j.bbrc.2026.154461_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202100605","article-title":"Enzyme\u2010activated prodrug\u2010based smart liposomes specifically enhance tumor hemoperfusion with efficient drug delivery to pancreatic cancer cells and stellate cells","author":"Duan","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.bbrc.2026.154461_bib19","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm.2537","article-title":"Tumor angiogenesis: molecular pathways and therapeutic targets","volume":"17","author":"Weis","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2026.154461_bib20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/jemt.10247","article-title":"Inhibition of angiogenesis at endothelial cell level","volume":"60","author":"Jekunen","year":"2003","journal-title":"MICROSC RES TECHNIQ"},{"key":"10.1016\/j.bbrc.2026.154461_bib21","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.cell.2017.10.009","article-title":"SnapShot: angiopoietins and their functions","volume":"171","author":"Saharinen","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2026.154461_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107608","article-title":"Targeting MYCN upregulates L1CAM tumor antigen in MYCN-Dysregulated neuroblastoma to increase CAR T cell efficacy","volume":"212","author":"Grunewald","year":"2025","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbrc.2026.154461_bib23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00441-003-0745-x","article-title":"Endothelial-pericyte interactions in angiogenesis","volume":"314","author":"Gerhardt","year":"2003","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.bbrc.2026.154461_bib24","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1248\/bpb.35.761","article-title":"Pericyte-coverage of human tumor vasculature and nanoparticle permeability","volume":"35","author":"Zhang","year":"2012","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bbrc.2026.154461_bib25","doi-asserted-by":"crossref","first-page":"6310","DOI":"10.1038\/s41467-021-26697-8","article-title":"Endothelial deletion of SHP2 suppresses tumor angiogenesis and promotes vascular normalization","volume":"12","author":"Xu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.154461_bib26","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/j.1440-1746.2007.04997.x","article-title":"Hypoxia and hepatocellular carcinoma: the therapeutic target for hepatocellular carcinoma","volume":"22","author":"Wu","year":"2007","journal-title":"J GASTROEN HEPATOL"},{"key":"10.1016\/j.bbrc.2026.154461_bib27","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1016\/j.yexcr.2006.05.018","article-title":"Hypoxia protects HepG2 cells against etoposide-induced apoptosis via a HIF-1-independent pathway","volume":"312","author":"Piret","year":"2006","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbrc.2026.154461_bib28","first-page":"565","article-title":"Involvement of hypoxia-inducible factor-1-alpha in multidrug resistance induced by hypoxia in HepG2 cells","volume":"24","author":"Zhu","year":"2005","journal-title":"J EXP CLIN CANC RES"},{"key":"10.1016\/j.bbrc.2026.154461_bib29","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature10169","article-title":"Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells","volume":"475","author":"Facciabene","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.154461_bib30","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1158\/0008-5472.CAN-15-0405","article-title":"Tumor-Promoting effects of Myeloid-Derived suppressor cells are potentiated by hypoxia-induced expression of miR-210","volume":"75","author":"Noman","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2026.154461_bib31","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1084\/jem.20131916","article-title":"PD-L1 is a novel direct target of HIF-1\u03b1, and its blockade under hypoxia enhanced MDSC-mediated T cell activation","volume":"211","author":"Noman","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbrc.2026.154461_bib32","doi-asserted-by":"crossref","first-page":"22642","DOI":"10.1074\/jbc.272.36.22642","article-title":"Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes","volume":"272","author":"Salceda","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.154461_bib33","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nm.1941","article-title":"Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors","volume":"15","author":"Reynolds","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2026.154461_bib35","first-page":"25","article-title":"Erythropoietin: physiology and clinical experience","volume":"27","author":"Varet","year":"1990","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.bbrc.2026.154461_bib36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.canlet.2018.10.008","article-title":"Hematopoietic growth factors and tumor angiogenesis","volume":"440\u2013441","author":"Ribatti","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2026.154461_bib37","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1161\/01.ATV.0000017728.55907.A9","article-title":"Regulation of endothelial cell survival and apoptosis during angiogenesis","volume":"22","author":"Chavakis","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2026.154461_bib38","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/74651","article-title":"Mechanisms of angiogenesis and arteriogenesis","volume":"6","author":"Carmeliet","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2026.154461_bib39","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/j.drudis.2021.07.024","article-title":"Recent advances in, and challenges of, anti-angiogenesis agents for tumor chemotherapy based on vascular normalization","volume":"26","author":"Wang","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bbrc.2026.154461_bib40","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1002\/ptr.8239","article-title":"A mechanistic insight into the anticancer potentials of resveratrol: current perspectives","volume":"38","author":"Bhuia","year":"2024","journal-title":"Phytother Res."},{"issue":"10","key":"10.1016\/j.bbrc.2026.154461_bib41","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41568-024-00736-0","article-title":"Targeting the tumour vasculature: from vessel destruction to promotion","volume":"24","author":"Guelfi","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154461_bib42","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ccell.2014.10.015","article-title":"Dual-Action combination therapy enhances angiogenesis while reducing tumor growth and spread","volume":"27","author":"Wong","year":"2015","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.bbrc.2026.154461_bib43","doi-asserted-by":"crossref","first-page":"905","DOI":"10.7150\/thno.11304","article-title":"Erythropoietin improves the accumulation and therapeutic effects of carboplatin by enhancing tumor vascularization and perfusion","volume":"5","author":"Doleschel","year":"2015","journal-title":"Theranostics"},{"issue":"9","key":"10.1016\/j.bbrc.2026.154461_bib44","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/j.celrep.2017.07.080","article-title":"Lysophosphatidic acid receptor 4 activation augments drug delivery in tumors by tightening endothelial cell-cell contact","volume":"20","author":"Takara","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbrc.2026.154461_bib45","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jconrel.2014.11.031","article-title":"Irinophore C\u2122, a lipid nanoparticulate formulation of irinotecan, improves vascular function, increases the delivery of sequentially administered 5-FU in HT-29 tumors, and controls tumor growth in patient derived xenografts of colon cancer","volume":"199","author":"Neijzen","year":"2015","journal-title":"J CONTROL RELEASE"},{"issue":"5","key":"10.1016\/j.bbrc.2026.154461_bib46","first-page":"2929","article-title":"Eribulin promotes antitumor immune responses in patients with locally advanced or metastatic breast cancer","volume":"38","author":"Goto","year":"2018","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154461_bib47","first-page":"401","article-title":"Mesenchymal-epithelial transition and tumor vascular remodeling in eribulin chemotherapy for breast cancer","volume":"38","author":"Kashiwagi","year":"2018","journal-title":"Anticancer Res."},{"issue":"3","key":"10.1016\/j.bbrc.2026.154461_bib48","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1158\/1535-7163.MCT-19-0358","article-title":"Eribulin suppresses clear cell sarcoma growth by inhibiting cell proliferation and inducing melanocytic differentiation both directly and via vascular remodeling","volume":"19","author":"Nakai","year":"2020","journal-title":"MOL CANCER THER"},{"issue":"10","key":"10.1016\/j.bbrc.2026.154461_bib49","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1111\/cas.12488","article-title":"Eribulin mesylate reduces tumor microenvironment abnormality by vascular remodeling in preclinical human breast cancer models","volume":"105","author":"Funahashi","year":"2014","journal-title":"Cancer Sci."},{"issue":"41","key":"10.1016\/j.bbrc.2026.154461_bib50","article-title":"Engineered oxygen factories synergize with STING agonist to Remodel tumor microenvironment for cancer immunotherapy","volume":"33","author":"Zhang","year":"2023","journal-title":"Adv. Funct. Mater."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26012258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26012258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:37:19Z","timestamp":1788950239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26012258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":50,"alternative-id":["S0006291X26012258"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154461","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Loureirin A, derived from Dragon's blood, promoted drug delivery and efficacy in pancreatic cancer via vascular promotion","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154461","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154461"}}